Status:
RECRUITING
Spyglass DS Peroral Cholangioscope Guided LL or EHL Versus BML for Endoscopic Removal of Complicated Bile Duct Stones
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Biliary Stones
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This study aims to compare the overall rate of endoscopic clearance of complicated bile duct stones by Spyglass DS peroral cholangioscopy guided holmium:YAG laser/electrohydraulic lithotripsy versus c...
Detailed Description
Currently, complicated bile duct stones are removed during endoscopic retrograde cholangiopancreatography (ERCP) by conventional mechanical lithotripsy, which means using a metal wire basket to captur...
Eligibility Criteria
Inclusion
- Patients with complicated biliary stones
- Patients older than 18 years old
- Patients where informed consent can be obtained
Exclusion
- Patients who cannot give informed consent
- Patients under 18 years old
- Pregnant or lactating patients
- Patient with altered gastrointestinal/biliary anatomy
- Patients with distal CBD malignant stricture from intrinsic or extrinsic causes
- Patients with ongoing cholangitis or biliary pancreatitis
- Patient with refractory bleeding tendencies (Platelet count \<50,000/mm3 or International Normalized Ratio \>1.5 despite correction with platelet or fresh frozen plasma transfusions)
- Patients with intrahepatic segmental stones
- Patients with contraindications to endoscopy due to comorbidities
Key Trial Info
Start Date :
June 14 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT03244163
Start Date
June 14 2016
End Date
December 1 2026
Last Update
September 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endoscopy Centre, Prince of Wales Hospital
Hong Kong, NT, Hong Kong